These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. McHugh NJ; Balachrishnan C; Jones SM Rheumatology (Oxford); 2003 Jun; 42(6):778-83. PubMed ID: 12730539 [TBL] [Abstract][Full Text] [Related]
3. Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis. Husted J; Gladman DD; Long JA; Farewell VT J Rheumatol; 1996 Nov; 23(11):1932-7. PubMed ID: 8923369 [TBL] [Abstract][Full Text] [Related]
4. Reporting of mortality in a psoriatic arthritis clinic is primarily a function of the number of clinic contacts and not disease severity. Bond S; Farewell VT; Schentag CT; Lawless JF; Gladman DD J Rheumatol; 2005 Dec; 32(12):2364-7. PubMed ID: 16331765 [TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Husted JA; Gladman DD; Farewell VT; Cook RJ Arthritis Rheum; 2001 Apr; 45(2):151-8. PubMed ID: 11324779 [TBL] [Abstract][Full Text] [Related]
7. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699 [TBL] [Abstract][Full Text] [Related]
8. Progression in psoriatic arthritis: role of time varying clinical indicators. Gladman DD; Farewell VT J Rheumatol; 1999 Nov; 26(11):2409-13. PubMed ID: 10555902 [TBL] [Abstract][Full Text] [Related]
9. Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis. Huemer C; Malleson PN; Cabral DA; Huemer M; Falger J; Zidek T; Petty RE J Rheumatol; 2002 Jul; 29(7):1531-5. PubMed ID: 12136915 [TBL] [Abstract][Full Text] [Related]
10. Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis. Husted JA; Gladman DD; Cook RJ; Farewell VT J Rheumatol; 1998 Nov; 25(11):2146-55. PubMed ID: 9818657 [TBL] [Abstract][Full Text] [Related]
11. Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic Arthritis. Husted J; Gladman DD; Farewell VT; Long JA J Rheumatol; 1996 Jun; 23(6):1015-9. PubMed ID: 8782133 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices. Gottlieb AB; Mease PJ; Mark Jackson J; Eisen D; Amy Xia H; Asare C; Stevens SR J Dermatolog Treat; 2006; 17(5):279-87. PubMed ID: 17092858 [TBL] [Abstract][Full Text] [Related]
13. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they? Butbul YA; Tyrrell PN; Schneider R; Dhillon S; Feldman BM; Laxer RM; Saurenmann RK; Spiegel L; Cameron B; Tse SM; Silverman ED J Rheumatol; 2009 Sep; 36(9):2033-41. PubMed ID: 19648305 [TBL] [Abstract][Full Text] [Related]
14. Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis. Morgan C; Lunt M; Bunn D; Scott DG; Symmons DP Rheumatology (Oxford); 2007 Dec; 46(12):1819-23. PubMed ID: 18032539 [TBL] [Abstract][Full Text] [Related]
15. The utility of the arthritis impact measurement scales for patients with psoriatic arthritis. Duffy CM; Watanabe Duffy KN; Gladman DD; Brubacher BB; Buskila D; Langevitz P; Farewell VT J Rheumatol; 1992 Nov; 19(11):1727-32. PubMed ID: 1491391 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Gisondi P; Girolomoni G; Sampogna F; Tabolli S; Abeni D Eur J Dermatol; 2005; 15(4):279-83. PubMed ID: 16048759 [TBL] [Abstract][Full Text] [Related]
17. The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients. Leeb BF; Andel I; Sautner J; Fassl C; Nothnagl T; Rintelen B Arthritis Rheum; 2007 Mar; 57(2):256-60. PubMed ID: 17330303 [TBL] [Abstract][Full Text] [Related]
18. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Healy PJ; Helliwell PS Arthritis Rheum; 2008 May; 59(5):686-91. PubMed ID: 18438903 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study. Mazzotta A; Esposito M; Costanzo A; Chimenti S Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444 [TBL] [Abstract][Full Text] [Related]
20. Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked. Williamson L; Dalbeth N; Dockerty JL; Gee BC; Weatherall R; Wordsworth BP Rheumatology (Oxford); 2004 Jun; 43(6):790-4. PubMed ID: 15113998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]